Related Experiment Video
Updated: Jun 24, 2026
05:06
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
2.5K
Do Web-Based Interventions Improve Well-Being in Type 2 Diabetes? A Systematic Review and Meta-Analysis
Michelle Hadjiconstantinou1, Jo Byrne, Danielle H Bodicoat
1Diabetes Research Centre, Department of Health Sciences, University of Leicester, Leicester, United Kingdom. mh333@le.ac.uk.
Journal of Medical Internet Research
|October 23, 2016
Summary
Web-based interventions show potential for improving well-being in type 2 diabetes patients, despite meta-analyses not finding significant improvements in depression or distress. Further research is needed to confirm these findings.
Area of Science:
- Digital Health
- Psychological Interventions
- Diabetes Management
Background:
- Poor diabetes self-care negatively impacts psychological well-being and quality of life.
- Web-based interventions offer a scalable platform for psychological support in chronic conditions.
- Limited evidence exists on the efficacy of web-based psychological support for type 2 diabetes.
Purpose of the Study:
- To systematically review and quantify the evidence on web-based interventions for improving well-being in type 2 diabetes patients.
- This is the first review to critically appraise and synthesize existing research in this area.
Main Methods:
- Systematic review of randomized controlled studies sourced from MEDLINE, EMBASE, CINAHL, PsycINFO, and Cochrane Library.
- Meta-analysis conducted for depression and distress outcomes.
- Included 16 studies in the review and 9 in the meta-analyses, analyzing behavior change techniques and intervention characteristics.
Main Results:
- Interventions lasting 2-6 months with professional-led, asynchronous/synchronous support showed potential for well-being improvements.
- Meta-analyses revealed no significant improvements in depression (P=.15) or distress (P=.43).
- Pooled mean difference for depression was -0.31 (-0.73 to 0.11) and for distress was -0.11 (-0.38 to 0.16).
Conclusions:
- Web-based interventions hold potential for enhancing psychological well-being in type 2 diabetes.
- Meta-analysis results for depression and distress were not statistically significant.
- Further research is necessary to validate the potential benefits of these digital interventions.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...